ABPOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ABPWW
Abpro Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.41+0.00 (+0.11%)
Close on Oct 19, 2026
- Market cap
- $2.41M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Mar 31, 2026, from 13F filings
Held by institutions
0M
Shares held, 13F filers
Institutional holders
0
0 new, 8 sold out
Net institutional buying
-0M
In Q1 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| The Goldman Sachs Group, Inc. | 196,537 | 6.80% | 13G (passive) | Dec 31, 2025 |
Top institutional holders
13F holdings as of Dec 31, 2025
| Holder | Shares | % of ABPO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Group Inc | 20,084 | – | $84.96K | New | 0.00% |
| Goldman Sachs Group Inc | 12,383 | – | $52.38K | New | 0.00% |
| Geode Capital Management, LLC | 10,785 | – | $45.62K | New | 0.00% |
| LMR Partners LLP | 2,084 | – | $8.82K | New | 0.00% |
| Clear Street Group Inc. | 436 | – | $1.84K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 436 | – | $1.84K | New | 0.00% |
| UBS Group AG | 315 | – | $1.33K | New | 0.00% |
| Bank Of America Corp /De/ | 15 | – | $64 | New | 0.00% |
| SBI Securities Co., Ltd. | 5 | – | $21 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | 0M | 0 / 0 | 0 / 8 | 0M | 0M |
| Q4 2025 | 9 | 0M | 9 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Jin Wook (Miles) Suk | CEO and Chairman, Director | 718,512 | Aug 4, 2025 |
| Ian Chan | Chief Executive Officer, Director, 10% owner | 8,652,800 | Nov 25, 2024 |
| Robert J. Markelewicz Jr. | Chief Medical Officer | – | Nov 15, 2024 |
| Soo Young Lee | Director | – | Aug 7, 2025 |
| Anthony D. Eisenberg | Director | – | Jul 29, 2025 |
| Ian McDonald | Director | – | Nov 18, 2024 |
| Abpro Bio International, Inc. | 10% owner | 16,507,334 | Nov 18, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jin Wook (Miles) Suk CEO and Chairman, Director | Jul 31, 2025 | Buy | +72,035 | $0.28 | $20.17K | 718,512 |
| Jin Wook (Miles) Suk CEO and Chairman, Director | Jul 25, 2025 | Award | +500,000 | – | – | 646,477 |
| Jin Wook (Miles) Suk CEO and Chairman, Director | May 19, 2025 | Buy | +16,200 | $0.26 | $4.21K | 146,477 |
| Jin Wook (Miles) Suk CEO and Chairman, Director | Apr 29, 2025 | Buy | +4,325 | $0.25 | $1.08K | 130,277 |
| Jin Wook (Miles) Suk CEO and Chairman, Director | Apr 24, 2025 | Buy | +26,542 | $0.34 | $9.02K | 125,902 |
| Jin Wook (Miles) Suk CEO and Chairman, Director | Apr 23, 2025 | Buy | +7,460 | $0.28 | $2.09K | 99,360 |
| Ian Chan Chief Executive Officer, Director, 10% owner | Nov 13, 2024 | Award | +987,400 | – | – | 987,400 |
| Ian Chan Chief Executive Officer, Director, 10% owner | Nov 13, 2024 | Award | +6,528,200 | – | – | 6,528,200 |
| Ian Chan Chief Executive Officer, Director, 10% owner | Nov 13, 2024 | Award | +1,137,200 | – | – | 1,137,200 |
| Jin Wook (Miles) Suk Co-CEO & Chairman, Director | Nov 13, 2024 | Award | +91,900 | – | – | 91,900 |
| Shahraab Ahmad Chairman and CEO, Director, 10% owner | Nov 7, 2023 | Other | −50,000 | – | – | 7,199,999 |
| Iqbaljit Kahlon Director | Nov 6, 2023 | Other | −50,000 | – | – | 0 |
| Shahraab Ahmad Chairman and CEO, Director, 10% owner | Nov 6, 2023 | Other | +50,000 | – | – | 7,249,999 |
| Dominick Schiano Director | Apr 18, 2023 | Option exercise | +50,000 | – | – | 50,000 |
| Joanna Lord Director | Apr 18, 2023 | Option exercise | +50,000 | – | – | 50,000 |
| Darren Stanwood Director | Apr 18, 2023 | Option exercise | +50,000 | – | – | 50,000 |
| Bryan Dove Director | Apr 18, 2023 | Option exercise | +50,000 | – | – | 50,000 |
| Coastal Acquisition Management II LLC Atlantic 10% owner | Apr 18, 2023 | Option exercise | +7,199,999 | – | – | 7,199,999 |
| Iqbaljit Kahlon Director | Apr 18, 2023 | Option exercise | +50,000 | – | – | 50,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.